Quick Takeaways
- Aberdeen Group plc filed SCHEDULE 13G for PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL).
- Disclosed ownership: 8.9%.
- Date of event: 31 Dec 2025.
Aberdeen Group plc - 31 Dec 2025 SCHEDULE 13G Report for PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL)
- Filing Manager
- Aberdeen Group plc
- Reporting Manager
- Aberdeen Group plc
- Symbol
- DTIL
- Shares outstanding
- 24,083,367 shares
- Disclosed Ownership
- 2,138,603 shares
- Ownership
- 8.9%
- Form type
- SCHEDULE 13G
- Filing time
- 27 Jan 2026, 10:10:23 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Aberdeen Group plc disclosed 8.9% ownership in PRECISION BIOSCIENCES INC Common Stock, par value $0.000005 per share (DTIL) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Jan 2026, 10:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Aberdeen Group plc | 8.9% | 2,138,603 | 0 | 2,138,603 | J. Clarke | Jenny Clarke/Major Shareholding Reporting Analyst | |
| abrdn Inc. | 8.9% | 2,138,603 | 0 | 2,138,603 | J. Clarke | Jenny Clarke/Major Shareholding Reporting Analyst |